GSK Loses Bid To Bar Testimony On Avandia Risks

Law360, New York (January 5, 2011, 1:54 PM EST) -- GlaxoSmithKline PLC has lost its bid to block three doctors from testifying about the alleged health risks of Avandia in a multidistrict litigation alleging the company concealed the diabetes medication's potential to cause heart attack and stroke in some patients.

Judge Cynthia M. Rufe of the U.S. District Court for the Eastern District of Pennsylvania denied GSK's motion to exclude three expert witnesses put forth by the plaintiffs' steering committee on Tuesday, following a Daubert hearing regarding the admissibility of their testimony.

GSK had argued that...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION


Case Number

2:07-md-01871

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Judge

CYNTHIA M. RUFE

Date Filed

October 18, 2007

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.